Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

NCT05310344 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Carcinoma
Platinum-resistant Ovarian Cancer
Recurrent Ovarian Carcinoma
Albumin-bound Paclitaxel
Bevacizumab
Survival Outcomes
Adverse Events

Interventions

COMBINATION_PRODUCT: Albumin-bound paclitaxel and bevacizumab

Sponsor

Lei Li